Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case–control study

被引：0
作者：
Zsófia Pethő
Edit Kalina
Zoltán Pap
Katalin Hodosi
Rebeka Falcsik
Ádám Balogh
Zoltán Szekanecz
Harjit Pal Bhattoa
机构：
[1] University of Debrecen,Kalman Laki Doctoral School of the University of Debrecen, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine
[2] University of Debrecen,Department of Laboratory Medicine, Faculty of Medicine
[3] University of Debrecen,Kalman Laki Doctoral School of the University of Debrecen, Department of Traumatology and Hand Surgery, Faculty of Medicine
[4] University of Debrecen,Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine
[5] University of Debrecen,Regional Osteoporosis Center, Department of Obstetrics and Gynecology, Faculty of Medicine
来源：
BMC Musculoskeletal Disorders | / 22卷
关键词：
Psoriatic arthritis; Areal and volumetric BMD; FRAX; Bone metabolism; Disease activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 220 条
[1]  
Myers WA(2006)Psoriasis and psoriatic arthritis: clinical features and disease mechanisms Clin Dermatol 24 438-447
[2]  
Gottlieb AB(2019)Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies Am Acad Dermatol 80 251-265.e19
[3]  
Mease P(1987)Psoriatic arthritis (PSA)--an analysis of 220 patients Q J Med 62 127-141
[4]  
Alinaghi F(2017)Psoriatic arthritis N Engl J Med 376 957-970
[5]  
Calov M(2016)Bone remodeling in psoriasis and psoriatic arthritis: an update Curr Opin Rheumatol 28 66-75
[6]  
Kristensen LE(2001)Osteoporosis prevention, diagnosis, and therapy Osteoporosis prevention, diagnosis, and therapy JAMA 285 785-795
[7]  
Gladman DD(2012)Inflammatory bone loss: pathogenesis and therapeutic intervention Nat Rev Drug Discov 11 234-250
[8]  
Coates LC(2016)Prevalence and risk factors of low bone mineral density in psoriatic arthritis: a systematic review Semin Arthritis Rheum 46 174-182
[9]  
Jullien D(2003)The Food and Drug Administration's osteoporosis guidance document: past, present, and future J Bone Miner Res 18 1125-1128
[10]  
Gladman DD(1993)The incidence of hip fracture in Europe Osteoporos Int 3 10-15
12345678910